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introduction: Bhutan is progressing toward malaria elimination. The purpose of this 
evaluation was to assess the ability of the surveillance system from 2006 to 2012 to 
meet the objectives of the Bhutan Vector-borne Disease Control Program (VDCP) and to 
highlight priorities requiring attention as the nation transitions to elimination.
Methods: The evaluation was conducted using the Center for Disease Control guidelines 
for evaluating public health surveillance systems. Data sources included a search of pub-
lically available literature, VDCP program data, and interviews with malaria surveillance 
personnel. Blood slide quality assurance and control through formal assessment of slide 
preparation and measures of between-reader correlation were performed.
results: Total malaria cases declined from 2006 to 2012. The average slide positivity 
rate decreased from 3.4% in 2006 to 0.2% in 2012. The proportion of non-residents in 
all cases increased to its highest value of 22.6% in 2012, and significant clustering in 
the border regions of India was noted, with Sarpang accounting for more cases than 
any other district from 2009 onward. Case detection was almost exclusively passive, 
but flexibility and sensitivity was demonstrated by the later addition of active case 
detection and specification of imported and locally acquired cases. Spatial data were 
limited to the village level, not allowing identification of transmission hotspots. For blood 
smears, statistical measures of between-reader agreement and predictive value were 
not computed. Blood smear quality was suboptimal by at least one criterion in over half 
of evaluated smears. Timeliness in reporting of cases was on a weekly to monthly basis, 
and did not meet the WHO goal of immediate notification.
conclusion: As of 2012, the national malaria surveillance system demonstrated flexi-
bility, representativeness, simplicity, and stability. The full potential for data analysis was 
not yet realized. Attaining the goal of malaria elimination will require system function 
enhancement through increased and more accurate case detection and rapid inves-
tigation, improved health worker training and accountability, focally targeted response 
measures, and, in particular, the challenge of finding re-introductions of infections from 
India. Many such measure have been undertaken or planned as part of the next phase 
of the Bhutan’s National Strategic Plan.
Keywords: Bhutan, elimination, epidemiology, malaria, surveillance
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inTrODUcTiOn
Greatly intensified efforts to control and prevent malaria on a 
global scale have resulted in substantial reductions in malaria-
associated morbidity and mortality, with global malaria deaths 
decreasing by 47%, and incidence by 30% from 2000 to 2013, 
according to World Health Organization (WHO) estimates (1, 
2). Aggressive control efforts have permitted many countries to 
begin the transition to elimination activities (1, 3), which specifi-
cally seek to interrupt local transmission. With increasingly finer 
focus, programs concentrate their attentions from the national 
scale to the residual foci of active transmission, and finally to 
individual cases (4, 5).
The WHO has suggested potential epidemiologic milestones 
for these transitions (3, 6). The move from a control program 
to a pre-elimination program involves the demonstration of 
a  blood slide positivity rate (SPR) of less than 5% for sus-
pected malaria cases. Subsequent transition to the elimination 
phase requires reaching an annual parasite index (API) of less 
than one case per thousand population at risk per year (4). 
Finally, WHO certification of malaria elimination requires a 
country to prove the absence of any locally acquired infections 
for a minimum of three consecutive years (4, 6). Once this is 
achieved, continued vigilance is required to prevent malaria 
resurgence (4, 7).
The small Himalayan nation of Bhutan (population 720,629 
in 2012) has had malaria control programs in place since 
1964 (8). Success of these programs has been measurable, as 
evidenced by dramatic decreases in malaria cases from nearly 
40,000 cases in 1994 to 45 cases in 2013 (9). Distribution of 
malaria transmission in Bhutan has been limited by its topog-
raphy and climate (10). Four northern districts experience 
essentially no malaria transmission as a result of their elevation, 
and any locally identified malaria cases are likely imported from 
outside districts or neighboring countries. Nine districts experi-
ence seasonal transmission during the summer months, while 
perennial transmission occurs in the seven southern districts 
bordering India (11). In 2011–2013, retrospective case mapping 
using Geographic Information System (GIS) was carried out, 
and districts have been reclassified as moderate, low, potential, 
and no transmission zones (8). Nationally, most cases occur 
in August and September, following the rainy season, with a 
secondary peak in April.
Two-thirds of all cases occur among males, and farmers are 
definitively the occupational group most at risk, followed by 
students and laborers (8). Bhutan’s proximity to India remains a 
major challenge to control as porous borders, and a large num-
ber of foreign workers are constant sources for new infections. 
Bhutan is surrounded by states with some of the highest SPRs 
for P. falciparum in India, and many of the foreign laborers come 
from the highly prevalent state of Orissa (1, 12).
The Plasmodium species endemic to Bhutan are P. falciparum 
and P. vivax (11, 13). Hypnozoites of P. vivax represent a major 
challenge to elimination efforts, functioning as an asympto-
matic reservoir of infection, which require additional specific 
therapies, namely primaquine, to eradicate these forms (14). 
Primaquine also targets the gametocyte stages of P. falciparum, 
making it a critical tool for reducing transmission, but its use 
is challenged by hemolytic anemia occurring in individuals 
with glucose-6-phosphate dehydrogenase (G6PD) enzyme 
deficiency (14, 15).
All vector-borne disease-related activities in Bhutan – includ-
ing surveillance, prevention, and outbreak control – are consoli-
dated under the Vector-borne Disease Control Program (VDCP), 
a division of the Department of Public Health, Ministry of Health 
of Bhutan. Since surveillance was initiated in 1965, reported 
cases reached a peak in 1994 of 39,852 malaria cases (13). Since 
then, the VDCP launched an aggressive malaria control strategy, 
strengthening and expanding earlier efforts. Following those 
efforts, malaria incidence in Bhutan has drastically reduced. 
Malaria dropped from the 16th leading cause of years of life lost 
in 1990 to the 46th in 2010 (16). Bhutan is in the elimination 
phase and is progressing well over the coming years to be certified 
by the WHO as malaria free (2).
Elimination rests on a country’s ability to interrupt transmis-
sion of malaria within its borders. Surveillance is lauded as a 
keystone for malaria elimination, and it must be tailored to 
the specific epidemiology, public health capacity, and disease 
control strategy of a given country. In the case of Bhutan, the 
clinical protocols and vector control activities of the VDCP 
have been reported previously (11, 13). The Centers for Disease 
Control and Prevention (CDC) has published guidelines on 
how to evaluate public health surveillance systems and includes 
assessments of data quality, timeliness in reporting, system 
simplicity, and data quality, among other measures (17). Using 
this framework, we sought to evaluate the Bhutanese surveil-
lance system as it strives to meet the objectives of the VDCP’s 
2012–2016 malaria strategic plan: (1) to reduce the number 
of malaria-related deaths to 0 by 2016 (shifted to 2018 in the 
2015–2012 National Strategic Plan), (2) to achieve 0 local 
malaria transmission by 2016, and (3) to obtain WHO malaria-
free certification by 2020 (17, 18).
MaTerials anD MeThODs
An evaluation of the Bhutan’s national malaria surveillance 
system from 2006 to 2012 was conducted using the CDC guide-
lines for evaluating public health surveillance systems (17). The 
guidelines focus on demonstrating that a surveillance system 
provides information that enhances public health decisions and 
describing system usefulness and attributes, including simplicity, 
flexibility, data quality, sensitivity, representativeness, timeliness, 
and stability. This report is structured based on these guidelines. 
Data were collected and analyzed in 2012 and 2013.
National malaria surveillance data from 2006 to 2012 were 
chosen for evaluation because these years align with the transition 
to the use of LLITNs and electronic record-keeping on the part 
of the VDCP and to achieve a finer focus on the pre-elimination 
years. Data were analyzed to determine numbers of blood slides 
collected and numbers of malaria cases by Plasmodium sp. and 
by district for each year during the study period. The evaluation 
included a search of PubMed, Google, and Google Scholar to 
identify studies pertaining to malaria in Bhutan. VDCP pro-
gram data including surveillance reports, standard operating 
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procedures, national documents were reviewed, and interviews 
with health workers, malaria technicians, district health officials, 
and VDCP personnel were conducted.
Finally, blood slide cross-check data for 2011 were analyzed 
including calculating the proportions meeting standards of 
preparation and percent agreement based on the results of the 
initial health center slide reading and the results from the VDCP 
cross-check. All data were analyzed using SAS 9.3 (SAS Institute 
Inc., NC, USA).
resUlTs
Description of the system
As of 2012, malaria surveillance in Bhutan was a vertical system 
coordinated by the VDCP headquartered in Gelephu. Passive 
malaria surveillance is conducted year-round across the entire 
population of Bhutan. While little to no active case detection 
was conducted over this time frame, active case detection at a 
few hydro-power project sites had begun in 2011 (8). All health 
care in the country was provided by the government, so any 
individual seeking formal care is theoretically covered by the 
national surveillance system through the basic health units 
(BHU) or district/regional/national referral hospitals. No private 
health-care clinics existed as of 2012. All cases in this system are 
reported to the VDCP in Gelephu. Febrile patients reporting to 
any health center were screened for malaria, and diagnosis were 
made by Giemsa-stained blood slide examination for the pres-
ence of parasites and speciation according to WHO guidelines 
(19). Rapid diagnostic tests (RDTs) had not been widely utilized 
as of 2012, and microscopy confirmation is always conducted 
on RDT results, unless microscopy is not available. A case was 
defined as anyone with Plasmodium spp. parasites on microscopy, 
regardless of parasite density.
From 2006 to 2012, the approach to treatment of patients 
infected with P. falciparum required infected patients to stay 
in the treating health-care facility during the 3-day treatment 
course of artemether–lumefantrine, a first-line artemisinin-based 
combination therapy (ACT). Starting in 2011, a single dose of 
primaquine was added immediately before discharge on day 3 as 
a part of pro-elimination efforts. In contrast, P. vivax cases were 
treated with a combination of chloroquine and primaquine (20).
For vector control, long-lasting insecticide-treated nets 
(LLINs) were rolled out in 2006 to replace the earlier insecticide-
treated bed nets that required regular re-impregnation. In 2010, 
the VDCP had achieved 96.9% coverage of households specifically 
targeted for LLINs, but in the endemic regions of southern Bhutan, 
only 77.2% of the population at risk were protected by LLINs (21). 
This country-wide coverage has remained stable according to 
indicator surveys in 2013, but achieve up to 99% in the Sarpang 
and Samdrup Jongkar districts (8, 22). Environmental larviciding 
had previously been a component of vector control strategies, but 
was discontinued in 2010. Focal indoor residual spraying (IRS) 
was conducted twice per year in areas of perennial transmission 
districts with a recent history of cases (23). Three sentinel sites for 
IRS and LLIN efficacy in the district of Sarpang had yet to find 
any evidence of insecticide resistance in Anopheline mosquitoes 
by 2012 (18).
Data collected through the national malaria surveillance 
system were analyzed by the VDCP and used to inform the plan-
ning of CDC activities at the local level, including targeted IRS 
and heightened efforts of community outreach, environmental 
management, and vector studies. Quarterly reports were sent 
from the VDCP to health centers, and a formal annual report was 
prepared for a review of the previous year with Ministry of Health 
officials. The village-level criteria used by the VDCP to determine 
where to conduct the twice-yearly (March and September) focal 
IRS were as follows: (1) P. falciparum cases accounting for over 
30% of total malaria cases during the three preceding years, (2) 
API above 10 cases per 1,000 population, (3) SPR above 10% for 
preceding 3  years, and (4) deaths due to malaria (23, 24). The 
2012 guidelines included the addition of focal IRS following a 
malaria index case if that area did not qualify for IRS under the 
above criteria (18).
Malaria surveillance results  
from 2006 to 2012
Overall, total malaria cases (including cases among both residents 
and non-residents of Bhutan) declined from 2,276 in 2006 to 106 
in 2012 (Figure  1). The exception was 2009 when there was a 
single-year increase to 1,098 cases; in 2010 cases dropped again 
to 465. Health workers and VDCP officials suspected this was 
due to waning efficacy of LLINs as the increase was not localized, 
but was rather seen across the country. Additional LLINs were 
distributed in early 2010. The district of Sarpang (in the region 
of perennial transmission) consistently had high numbers of 
cases, and accounted for the majority of cases from 2009 onward. 
Over the 7-year period, 15 malaria-attributable deaths occurred, 
decreasing from four in 2006 to a single death in 2012. No deaths 
were reported in 2013, suggesting that the VDCP’s zero-mortality 
goal is achievable (8). Further reductions in malaria cases were 
reported in 2013, with 45 microscopy-confirmed cases (8).
Slide positivity rate and API both decreased over this 
period, surpassing WHO milestones for program transition to 
pre-elimination and elimination [Table  1; Figure  2 (4)]. The 
SPR (including cases among both residents and non-residents of 
Bhutan) was below 5% for all three levels of regional transmission 
for the duration of the 7-year period, with the national average 
decreasing from 3.4% in 2006 to 0.2% in 2012. API fell below 
one case per thousand population in districts with perennial 
transmission in 2011, while API for regions of seasonal and no 
malaria transmission were less than 0.5 throughout.
Importantly, designation of resident/non-resident status from 
2006 to 2012 did not take into account travel history or other 
case investigation history. Thus, this designation did not equate 
to local versus imported case definitions. In late 2012, case 
definitions were adjusted to consider the likely source of malaria 
acquisition, an important step in reaching the goal of elimination. 
Using the prior definitions, non-residents comprised between 6.2 
(in 2010) and 22.6% (in 2012) of all cases (Figure 1). However, 
these cases were not evenly distributed across all districts; rather, 
there were more transient, localized effects in particular districts, 
changing from year to year. In 2011, every non-resident case was 
detected in Sarpang, where they accounted for 45 of 148 total cases 
TaBle 1 | Total numbers of blood slides examined and slide positive rate, 
by year.
Year
2006 2007 2008 2009 2010 2011 2012
Blood slides 
examined
66,079 51,446 47,268 62,342 54,616 44,481 42,512
Slide positivity 
rate
3.4% 1.7% 0.8% 1.8% 0.9% 0.5% 0.2%
FigUre 1 | Malaria cases in Bhutan 2006–2012 by residency status, as defined during this time period. All cases are microscopy-confirmed.
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(30.4%). In 2012, cases among non-residents were only reported 
in Wangdue and Sarpang, accounting for 7 of 15 (46.7%) of cases 
in Wangdue and 17 of 67 (25.4%) of cases in Sarpang. Data from 
2013, suggest a shift to more cases occurring in non-residents 
than in Bhutanese, on a national scale (8).
Proportions of infections by species (P. falciparum, P. vivax, or 
mixed infection) did not vary significantly over time (Figure 3). 
From 2006 to 2012, P. vivax accounted for nearly two-thirds of 
all infections in seasonal transmission and malaria-free districts, 
while an additional 22.3–25.0% were due to P. falciparum and 
12.3–13.0% were mixed. In the perennial transmission districts, 
infections were more evenly split between P. falciparum and P. 
vivax (43.1 and 48.6%, respectively; 8.3% mixed), perhaps due to 
the high burden of P. falciparum in neighboring Assam (25, 26). 
Figure 4 shows the parasite species and patient residency status 
over the evaluation period.
system Usefulness and attributes
The system alerted VDCP officials to the 2009 malaria outbreak – 
leading to the distribution of additional LLINs in 2010 – and had 
tracked the more local trends, such as the reduction in incidence 
in Samdrupjonkar, which had formerly had rates comparable to 
those of Sarpang. Sarpang was identified as the major contributor 
of cases, and the district was targeted for additional control efforts. 
VDCP were able to utilize. Data, though useful in the scenarios 
above, were not analyzed to its full potential. For example, spatial 
data were collected only at the village level, though an even finer 
scale of spatial analysis would be useful for the identification of 
transmission hotspots (27, 28). Importantly, beginning in 2011, 
the VDCP had begun to introduce retrospective case mapping 
using GIS to identify evidence-based strategies for targeted 
interventions, an important advance for achieving and sustaining 
elimination (8).
Data Quality and Positive Predictive Value
Health centers that had treated febrile patients within the last 
month were required to send a portion of blood slides, which 
had been collected to the VDCP for cross-checking by a trained 
professional. Health centers with fewer than 50 fever patients 
were required to send in all of their slides, while those with 50 or 
more were required to send all of their positive slides and 10% of 
their negative slides for cross-checking. Slides were reviewed by 
an official at the VDCP with more advanced parasitology training 
to assess accuracy in initial diagnosis. The official was blinded 
to the initial result while slides were examined for the presence 
of species of parasites. The size, evenness, staining, and cleanli-
ness (dichotomously, acceptable or not), as well as whether the 
slide includes both thick and thin smears as required by VDCP 
protocols (23), were recorded.
The inclusion of the blood slide cross-checking process allowed 
for evaluation of the validity of diagnoses. Of 2,514 blood slides 
analyzed during the 2011 cross-check process, 1,160 (46.14%) 
were judged by the VDCP official to be of excellent quality 
(programmatically defined as free from any staining problems or 
blemishes, and containing both thin and thick smears). Over half 
of smears were judged to be sub-optimal in at least one charac-
teristic. The greatest deficit was that only 56% of slides had been 
prepared with both a thick and thin smear (38% only had a thick 
smear prepared). Lower than expected numbers of blood slides 
sent in for confirmation may suggest a lack of acceptability in this 
FigUre 2 | indicators of program progress: slide positivity rate (sPr) 
and annual parasite index (aPi) from 2006 to 2012. Includes cases in 
residents and non-residents. Figures further stratified by district level of 
transmission intensity (no transmission, seasonal, perennial).
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portion of the process. Other deficits were much less frequently 
encountered (91% of smears were of a normal size, 88% were 
evenly prepared, and 93% were stained satisfactorily). Sixty slides 
(2.4%) arrived broken at the VDCP and could not be read for 
cross-checking.
At the time of the assessment, false positives and false nega-
tives were counted, but no percentages or measures of agreement 
were computed. The WHO recommends calculating percent 
agreement between health worker and validator reading for the 
presence of any parasites and for the presence of P. falciparum 
specifically (29). Where slide readings from both the original 
health worker and the VDCP professional during cross-check 
could be compared, agreement of parasite presence or absence 
of parasites was >97% for districts of all three transmission levels 
(Table 2). However, in 2011, readings from two health centers 
accounted for 12 of 19 false positives (all of which were identified 
as P. vivax infections). Positive predictive value (PPV), or the 
proportion of positive results that represent true positives, was 
not explicitly calculated, an important measure as true incident 
cases continue to decline. Similarly, negative predictive value 
(NPV), or the proportion of negative results that represent true 
negatives were not calculated, an important measure as miss-
ing cases poses a risk for severe disease sequelae and onward 
transmission.
sensitivity and acceptability
Two major factors determine the sensitivity of the system: 
patients’ health care-seeking behavior and the ability to properly 
assess blood slides, which was discussed earlier (30). According 
to the 2009 National Malaria Indicator Survey and Bed Net 
Knowledge, Attitude, and Practice Study (MIS & KAP) of 796 
households, 745 (93.6%) knew what malaria was, 663 (83.3%) 
identified fever (the criteria for blood screening in health cent-
ers) as a major symptom, and 83.5% reported seeking care within 
24 h of a fever. Regarding treatment, 739 (92.8%) respondents 
said that malaria could effectively be treated by visiting a health 
center, while only 3 (0.4%) respondent said treatment could 
be achieved by visiting a traditional healer or astrologer (21). 
Increasing public awareness and encouraging individuals to go to 
health-care centers when they experience a fever has been a focus 
of the VDCP’s malaria control strategy. More recent indicator 
surveys show progress in this area (22). The sensitivity of the 
system was also demonstrated with the piloting of active case 
detection in hydro-power project sites beginning in 2011, and 
the addition of both reactive and an expansion of active case 
detection activities is a part of Bhutan’s 2015–2020 strategy for 
malaria elimination (3, 8, 31).
Timeliness and Flexibility
Currently, the WHO recommends that malaria eliminating 
countries should target the reporting of all cases to the district 
or intermediate level with a copy to the central level immediately, 
ideally the same day, by telephone, SMS, or e-mail (32). All health 
center records and surveillance reports were completed on paper 
and delivered by post, fax, or by car to the VDCP. Health centers 
sent in reports to the VDCP every month, except for those in the 
seven endemic districts which reported weekly by phone (23). 
Reports for a given month were to be received by the VDCP 
by the beginning of the second week of the following month, 
although some reports were received up to 2 months after this due 
to distance of particular BHU or seasonally-disrupted terrain. All 
data were received by the Information Unit of the VDCP, and 
since 2006 had been entered into Epi Info (Centers for Disease 
Control and Prevention, Atlanta).
The CDC defines flexibility as a system that “can adapt to 
changing information needs or operating conditions with little 
additional time, personnel, or allocated funds” (17). Flexible 
systems are also those that can accommodate “changes in case 
definitions or technology and variations in funding or reporting 
sources” (17). Structurally, Bhutan’s system appeared able to 
accommodate new components such as phone reporting and 
reactive case detection. As described above, Bhutan now plans to 
TaBle 2 | agreement of slide readings during cross-check in 2011.
Malaria-free districts Seasonal transmission districts
VDCP cross-check VDCP cross-check
Positive Negative Positive Negative
Health  
worker
Positive 3 1 Health  
worker
Positive 6 9
Negative 1 88 Negative 0 377
Agreement = 97.9% Agreement = 97.7%
Perennial transmission districts National total
VDCP cross-check VDCP cross-check
Positive Negative Positive Negative
Health  
worker
Positive 98 9 Health  
Worker
Positive 107 19
Negative 13 1910 Negative 14 2375
 Agreement = 98.9% Agreement = 98.8%
FigUre 3 | Malaria cases in Bhutan 2006–2012 by species of Plasmodium. Categories are P. falciparum, P. vivax, and mixed species infection.
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introduce more active case detection and more stringent defini-
tions of local versus imported cases. Elimination efforts require 
on-going review of the progress of the program and evaluation 
of the performance of the surveillance system (32). To this end, 
the system has demonstrated flexibility through external reviews 
and the continued evolution of its malaria strategy over time. In 
addition, there is the potential for the malaria surveillance system 
to demonstrate its flexibility in other ways, such as the expan-
sion to include surveillance for other diseases notifiable diseases. 
However, no indication of such expansion was evident at the time 
of this review.
representativeness and simplicity
Surveillance was complete across the country and included 
the provision of reports even in the absence of cases identified 
during the period. Bhutan lacks a private health-care sector, and 
all Bhutanese attend government health-care centers, all of which 
report to the VDCP. Although structurally consistent throughout 
the country, the system does not appear to be completely uniform 
in its quality of coverage, with BHUs in the endemic districts hav-
ing higher numbers of blood slides collected. However, due to the 
climate of Bhutan and the ecological restriction of the mosquito 
vector to the southern districts, imperfect representativeness may 
be less detrimental.
The system as it currently stands is quite simple. As a result 
of the VDCP’s functional autonomy, there are no intervening 
entities between the point of diagnosis and the center of data 
receipt and analysis. During the time of this assessment, a hand-
ful of private laboratories were beginning to emerge, which could 
impact on simplicity, although no data were obtained from these 
settings.
stability
Stability is defined as “the reliability (i.e., the ability to collect, 
manage, and provide data properly without failure) and avail-
ability (the ability to be operational when it is needed) of the 
public health surveillance system” (17). In many ways, the cur-
rent simplicity and low reliance on technology render the malaria 
surveillance system quite structurally stable and resilient in the 
face of obstacles such as power outages, though the growth of 
internet and other mobile technology poses new challenges to 
stability. An additional identified challenge will be how to sustain 
high quality surveillance and aggressive control efforts as funding 
decreases. The VDCP and its malaria control activities are funded 
by the Royal Government of Bhutan, the Government of India, 
the WHO, and the Global Fund (GFATM) (31). International 
funding had suffered as a result of the global financial crisis over 
this time period (33).
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DiscUssiOn
We aimed to assess the malaria surveillance system in Bhutan 
from 2006 to 2012 using CDC guidelines for the evaluation of 
public health surveillance systems. It should be noted that since 
our assessment, many of the recommendations described herein 
have been either enacted or planned as described in Bhutan’s 
updated 2015 to 2020 National Strategic Plan (8). Notably, a 
recent external review was conducted in collaboration with the 
WHO, and recommendations from this review are outlined in the 
strategic plan. Overall, from our assessment, the malaria surveil-
lance system of Bhutan appeared strong and produced data that 
was useful and of good quality. The performance of the system 
has been critical to the major reductions to malaria morbidity and 
mortality in Bhutan. However, elimination will require the system 
to function at an even higher level, and measures are underway to 
meet this challenge (Table 3).
Our assessment of blood smear cross-check data from 2011 
revealed a deficiency in diagnostic accuracy. This will require the 
addition of measures of reader agreement, additional training for 
local health workers, more rigorous attention to individual worker 
performance, and remedial measures when required. The predic-
tive power of negative results is of particular significance because 
of consequences to an individual and as a source for future infec-
tions. The existence of a quality assurance component is a great 
strength of the structure of this surveillance system, but it is only 
of value if the results are utilized. Health worker accountability 
should be improved. While health centers that have repeated 
FigUre 4 | Malaria cases in Bhutan 2006–2012 by species of infection among residents and non-residents.
TaBle 3 | Priority action recommendations.
Priority actions
Enhanced data management and analysis: The surveillance system utilizes a 
fraction of the information, which is collected, and harnessing this information 
more effectively could aid in pro-elimination efforts. Addition of a calculation, such 
as percent agreement of slide readings, can provide a way to compare districts 
and the national average, to assess progress over time, and to meaningfully 
communicate with outside public health entities.
Optimize diagnostic capacity: Additional immediate training for local health 
workers is a necessity, as well as a more rigorous attention to individual worker 
performance. Routine refresher training should be required. Competency will 
be difficult to maintain in an era of elimination, so continued monitoring will be 
necessary.
Improved timeliness: Standardizing telephone reporting is a potential avenue. The 
VDCP may consider incorporating the proportion of P. falciparum infections with 
gametocytes present as an indicator of timeliness of patient diagnosis for use 
during the cross-check process. Timeliness will likely improve with expansion of 
digital access and potential SMS based reporting.
Active case detection: This should include active screenings in the vicinity 
of locally acquired infections, as well as a more pro-active approach toward 
imported infections. Active screenings as a prerequisite for foreign workers would 
be a significant step in the control of cross-border malaria.
Formalization of cross-border collaboration: A major obstacle for the elimination 
of malaria in Bhutan will be ongoing reintroductions of malaria through porous 
borders and migrant laborers. Unified efforts between India and Bhutan are 
required.
Expansion of surveillance apparatus to include other diseases. The successes 
of the malaria surveillance system can be leveraged in the control of emerging 
vector-borne diseases in Bhutan, such as dengue, leishmaniasis, and 
chikungunya.
Additional studies into G6PD prevalence and vector ecology: Though not 
detailed in this assessment, G6PD prevalence must be determined; the hazard 
of using primaquine as a standard treatment in the absence of this knowledge is 
great, and monitoring should be conducted adverse reactions. Research into the 
ecological epidemiology of malaria in Bhutan, including vector incrimination and 
environmental drivers of transmission, would allow targeted vector control as well 
as forward-looking risk assessment for challenges such as climate change
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errors identified through the cross-check process are invited to 
send health workers to refresher trainings at the VDCP, workers 
are often not sent. This process should be formalized and made to 
be a requirement with set expectations for performance (29). The 
WHO and others recommend a system of on-going training and 
assessment of microscopists for competency in slide preparation 
and reading of both parasite presence and species, coupled with a 
clear protocol for remedial measures if expectations are not met 
(29, 34). District health centers must be encouraged to continue 
to send in the required number of blood slides as the blood slide 
cross-checking process is the primary means by which the VDCP 
can assess the sensitivity and specificity of diagnoses. Plans for 
the establishment of a National Quality Assurance system for 
malaria diagnosis should assist in making these adjustments (8). 
In addition, as new private laboratories are emerging in Bhutan, 
the VDCP should ensure that similar proficiency testing occurs 
in these centers as well.
Second, more sophisticated data management and analyses 
were required. The malaria surveillance system in Bhutan col-
lected more information than was utilized, and harnessing this 
information more effectively would have aided in pro-elimination 
efforts. At a national level, training of personnel in statistics and 
epidemiology represented a significant challenge. As this is 
being addressed, data such as slide-reader agreement should be 
added to standard analyses. In addition, SPR calculated monthly 
at BHUs (instead of only at the year-end) may help to better 
understand the local transmission as compared to the raw case 
counts. These calculations can provide a way to compare districts 
and the national average, to assess progress over time, and to 
meaningfully communicate with outside entities concerned with 
public health.
Third, timeliness of identifying and treating cases is an area for 
improvement. The WHO has suggested using the proportion of 
P. falciparum infections with gametocytes present as a timeliness 
indicator, as treatment of P. falciparum infections within the first 
6 days from the onset of symptoms is felt to be sufficient to prevent 
the development of gametocytes (6). The VDCP therefore may 
consider incorporating this indicator into its protocols. Ideally, 
the presence of gametocytes and resulting proportion should be 
recorded and calculated at the point of care.
In addition, to improve timeliness of reporting, signifi-
cant enhancements will be needed to meet the WHO goal of 
“immediate” reporting of cases to national malaria programs 
(32). In the short-term, phone-based reporting, which is already 
regularly practiced with success in the southern districts, could 
be expanded to the seasonal transmission districts, potentially as 
a transient feature activated during the high case season. In the 
mid- to long-term, electronic reporting will enhance timeliness, 
but improved funding and training to expand internet access, 
acquire computers, and attain necessary technical expertise 
levels is required. With the advent of GIS case mapping, along-
side the growth of mobile and internet capacity, significant 
improvements in timeliness is expected. Several countries have 
established SMS reporting systems with much success, including 
Sri Lanka in 2009 (35–38).
Fourth, from 2006 to 2012, the program functioned primar-
ily in a passive detection capacity, but programmatic changes 
toward both reactive and active case detection are now underway 
(8). In several other countries, reactive case detection has suc-
cessfully been used to focally increase sensitivity by requiring 
active blood screens of household members and other residents 
within a defined radius of any newly identified malaria case (35, 
39). In addition, since 2012, case definitions have been modified 
to appropriately designate cases as imported or locally acquired, 
data which are critical to achieve and sustain elimination (26, 
40). The addition of genetic analysis of parasites to confirm 
whether infections are locally acquired or imported would not 
seem to substantially challenge the structure of the current 
system (41). With such changes, the surveillance system will 
have to tighten its coverage, as reintroductions from porous 
borders and migrant workers will be an ongoing major threat 
to both achieving and sustaining elimination. The results of 
these case investigations then must be mined at the program 
level to attack foci of transmission and to implement targeted 
measures addressing populations identified as having the great-
est risk, due to geographic location or occupational hazard 
(1, 27). Importantly, the use of spatial decision support systems, 
including GIS, is now underway, and will aid the in identify-
ing hotspots and hotpops, and the deployment of targeted 
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intervention strategies. In addition, targeted active screenings 
of workers at hydro-power project sites is underway. While this 
is an important step, care must be taken to ensure that workers 
do not become averse to seeking care for fear of loss of work 
privileges. In addition, innovative means of exposure reduction 
will have to be developed to prevent infection in other at-risk 
groups such as farmers, who are not protected by the primary 
vector control activities of IRS and LLIN use. In this case, the 
malaria surveillance system has been successful in identifying an 
at-risk population, but this information has not been translated 
into public health action.
The Roll Back Malaria initiative suggests that countries with 
highly malarious borders may choose to postpone elimination 
efforts until neighboring countries are able to control their high 
incidence levels (3) Delaying elimination efforts until control is 
achieved in India would mean a substantial delay. However, in 
the absence of effective surveillance and health service delivery 
in Assam, this state and its neighbors will continue to act as 
a source for re-introduction of infections in southern Bhutan 
(42). Cross-border collaborations have been limited, but they 
will have to be a priority for both countries to see case reduc-
tions in this area. Available funding for such collaborations, 
however, is limited (43). The Asia Pacific Malaria Elimination 
Network raises awareness of the collective progress of and chal-
lenges for elimination in the region acts as a catalyst to achieve 
consensus on important elimination issues, such as mobility 
and migration (9).
Finally, and more broadly, the successes of the VDCP and 
the malaria surveillance system can be leveraged in the control 
of emerging vector-borne diseases in Bhutan such as dengue, 
leishmaniasis, and chikungunya. Integrated vector management 
strategies can be used to progress toward elimination even as the 
spread of these other diseases is controlled, and the surveillance 
apparatus for malaria could be expanded to fill the present void of 
systematic surveillance of other vector-borne diseases.
Our evaluation had several limitations. The analysis of blood 
slide quality data could have been strengthened by an expert 
review of a random sample of all blood slides (both those sent in 
to the VDCP and those collected at BHUs but not sent in) as well 
as a direct assessment slide reading proficiency of local health 
workers and VDCP officials. Nevertheless, we believe that our 
assessment of the design and function of the surveillance system 
is well-founded despite these potential limitations.
Bhutan has seen major reductions in malaria morbidity 
and mortality since the 1994 peak of cases, and a substantial 
dwindling from 2006 to 2012, and major advances evident in 
2013 data. Surveillance has played an important role in the ability 
of the VDCP to provide high quality, targeted control services to 
the foci of transmission during this period. Bhutan is continuing 
to develop and expand its surveillance system, and the addition 
of targeted active and reactive case detection, along with GIS 
data will be beneficial. The malaria elimination community must 
ensure that Bhutan does not become a victim of its own success, 
and that donors who have provided substantial support in the past 
do not turn their attention to other countries. Studies of malaria 
resurgence have found that nearly all instances of resurgence are 
due to the slackening of control efforts, which are themselves 
primarily due to insufficient resources (7, 40). In the absence of 
any external reduction in regional transmission potential, the 
activities used to achieve malaria control or elimination must 
be maintained (44). Despite such challenges and the potential of 
re-introductions of infections, elimination in Bhutan in the next 
few years appears possible with the continued responsiveness and 
adaptability of its surveillance system that has been demonstrated 
to date.
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